Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACOR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Acorda Therapeutics stock price on Thursday which ended trading at $13.21
(Updated on Mar 28, 2024)

Hold candidate since Mar 28, 2024 PDF

The Acorda Therapeutics stock price gained 10.92% on the last trading day (Thursday, 28th Mar 2024), rising from $11.91 to $13.21. During the last trading day the stock fluctuated 12.65% from a day low at $11.82 to a day high of $13.32. The price has fallen in 7 of the last 10 days but is still up by 2.05% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 thousand more shares were traded than the day before. In total, 4 thousand shares were bought and sold for approximately $56.36 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -23.42% during the next 3 months and, with a 90% probability hold a price between $8.49 and $10.76 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ACOR Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, March 27, 2024, and so far it has risen 10.92%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Acorda Therapeutics has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Acorda Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $13.47. On a fall, the stock will find some support from the short-term average at $12.32. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Acorda Therapeutics stock

Acorda Therapeutics finds support from accumulated volume at $13.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.50 between high and low, or 12.65%. For the last week, the stock has had daily average volatility of 4.79%.

Our recommended stop-loss: $12.69 (-3.94%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (ACOR) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Acorda Therapeutics to open at $12.78, and during the day (based on 14 day Average True Range), to move between $12.40 and $14.02, which gives a possible trading interval of +/-$0.81 (+/-6.10%) up or down from last closing price. If Acorda Therapeutics takes out the full calculated possible swing range there will be an estimated 12.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $13.30 (0.67%) than the support at $13.01 (1.52%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Acorda Therapeutics stock A Buy?

Acorda Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.853 Hold/Accumulate Upgraded

Predicted Opening Price for Acorda Therapeutics of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$12.78 ( 3.25%) $13.21

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ACOR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 14.28 8.07 %
R2 13.71 3.75 %
R1 13.35 1.08 %
Current price: 13.21
Support S1 12.21 -7.57 %
S2 11.86 -10.24 %
S3 11.29 -14.56 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 16.32 23.53 %
R2 13.50 2.19 %
R1 13.30 0.674 %
Current price 13.21
Support S1 13.01 -1.52%
S2 13.00 -1.60%
S3 12.10 -8.41%

FAQ

What is the symbol for Acorda Therapeutics Stock and on which exchange is it traded?
The symbol for Acorda Therapeutics is ACOR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Acorda Therapeutics Stock?
Acorda Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Acorda Therapeutics Stock?
Acorda Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Acorda Therapeutics Stock.

What's the current price of Acorda Therapeutics Stock?
As of the end of day on the 2024-03-28, the price of an Acorda Therapeutics (ACOR) share was $13.21.

What is the 52-week high and low for Acorda Therapeutics Stock?
The 52-week high for Acorda Therapeutics Stock is $18.21 and the 52-week low is $0.449.

What is the market capitalization of Acorda Therapeutics Stock?
As of the 2024-03-28, the market capitalization of Acorda Therapeutics is 16.409M.

When is the next earnings date for Acorda Therapeutics?
The upcoming earnings date for Acorda Therapeutics is Apr 01, 2024.
Click to get the best stock tips daily for free!

About Acorda Therapeutics

Acorda Therapeutics Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS p... ACOR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT